CVI Investments, Inc. 13D and 13G filings for ReShape Lifesciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 12:11 pm Sale | 2025-03-31 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 200,000 5.700% | -144,626 (-41.97%) | Filing |
| 2025-02-21 10:33 am Purchase | 2025-02-18 | 13G | ReShape Lifesciences Inc. RSLS | CVI Investments, Inc. | 344,626 9.900% | 344,626 (New Position) | Filing |